NEW YORK, March 02, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against ICON plc (NASDAQ:ICLR) and certain of its senior executives for potential violations of the federal securities laws.
If you invested in ICON, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/icon-plc.
Investors have until April 11, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased ICON securities. The case is pending in the U.S. District Court for the Eastern District of New York and is captioned Shing v. ICON plc, et al., No. 25-cv-00763.
Why was ICON Sued for Securities Fraud?
ICON is a clinical research organization (“CRO”) that provides a range of services to help its pharmaceutical company customers bring new drugs to market. In recent years, many large pharmaceutical companies have implemented drastic cost reduction programs, including shifting part of their clinical studies in-house …
